{"id":1432,"date":"2026-11-09T13:52:01","date_gmt":"2026-11-09T12:52:01","guid":{"rendered":"https:\/\/atonco-pharma.com\/?p=1432"},"modified":"2026-11-09T13:52:01","modified_gmt":"2026-11-09T12:52:01","slug":"a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211","status":"publish","type":"post","link":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/","title":{"rendered":"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Investigations on dose deposition in superficial bladder lesions following endocavitary administration were presented at EANM 2026 congress, in Vienna.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This work was performecd by N. Varmenot from Institut de Canc\u00e9rologie de l&#8217;Ouest in collaboration with Atonco and University of Michigan Medical Center, Ann Arbor<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Link to the document :<\/strong> <a href=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EP-1239-2.pdf\">https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EP-1239-2.pdf<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investigations on dose deposition in superficial bladder lesions following endocavitary administration were presented at EANM 2026 congress, in Vienna. This work was performecd by N. Varmenot from Institut de Canc\u00e9rologie de l&#8217;Ouest in collaboration with Atonco and University of Michigan Medical Center, Ann Arbor Link to the document : https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EP-1239-2.pdf<\/p>\n","protected":false},"author":5,"featured_media":1443,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,47],"tags":[],"class_list":["post-1432","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-categorise","category-other-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211 - Atonco<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211 - Atonco\" \/>\n<meta property=\"og:description\" content=\"Investigations on dose deposition in superficial bladder lesions following endocavitary administration were presented at EANM 2026 congress, in Vienna. This work was performecd by N. Varmenot from Institut de Canc\u00e9rologie de l&#8217;Ouest in collaboration with Atonco and University of Michigan Medical Center, Ann Arbor Link to the document : https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EP-1239-2.pdf\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T12:52:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EANM-26.png\" \/>\n\t<meta property=\"og:image:width\" content=\"756\" \/>\n\t<meta property=\"og:image:height\" content=\"371\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Elise\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elise\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/\"},\"author\":{\"name\":\"Elise\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\"},\"headline\":\"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211\",\"datePublished\":\"2026-11-09T12:52:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/\"},\"wordCount\":66,\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/EANM-26.png\",\"articleSection\":[\"Actualit\u00e9\",\"Other news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/\",\"name\":\"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211 - Atonco\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/EANM-26.png\",\"datePublished\":\"2026-11-09T12:52:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/#primaryimage\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/EANM-26.png\",\"contentUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/EANM-26.png\",\"width\":756,\"height\":371},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/11\\\/09\\\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\",\"name\":\"Elise\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"caption\":\"Elise\"},\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/author\\\/administration\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211 - Atonco","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/","og_locale":"en_US","og_type":"article","og_title":"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211 - Atonco","og_description":"Investigations on dose deposition in superficial bladder lesions following endocavitary administration were presented at EANM 2026 congress, in Vienna. This work was performecd by N. Varmenot from Institut de Canc\u00e9rologie de l&#8217;Ouest in collaboration with Atonco and University of Michigan Medical Center, Ann Arbor Link to the document : https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EP-1239-2.pdf","og_url":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/","og_site_name":"Atonco","article_published_time":"2026-11-09T12:52:01+00:00","og_image":[{"width":756,"height":371,"url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EANM-26.png","type":"image\/png"}],"author":"Elise","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Elise","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/#article","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/"},"author":{"name":"Elise","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa"},"headline":"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211","datePublished":"2026-11-09T12:52:01+00:00","mainEntityOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/"},"wordCount":66,"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EANM-26.png","articleSection":["Actualit\u00e9","Other news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/","url":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/","name":"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211 - Atonco","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/#primaryimage"},"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EANM-26.png","datePublished":"2026-11-09T12:52:01+00:00","author":{"@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa"},"breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/#primaryimage","url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EANM-26.png","contentUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/11\/EANM-26.png","width":756,"height":371},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/2026\/11\/09\/a-dosimetric-study-of-bladder-endocavitary-therapy-using-astatine-211\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"A DOSIMETRIC STUDY OF BLADDER ENDOCAVITARY THERAPY USING ASTATINE-211"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa","name":"Elise","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","caption":"Elise"},"url":"https:\/\/atonco-pharma.com\/en\/author\/administration\/"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1432"}],"version-history":[{"count":9,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1432\/revisions"}],"predecessor-version":[{"id":1453,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1432\/revisions\/1453"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media\/1443"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=1432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=1432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}